FALANGA, ANNA

FALANGA, ANNA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 153 (tempo di esecuzione: 0.021 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients 01 - Articolo su rivista 2022 Marchetti, MarinaVerzeroli, CristinaRizzi, MarcoFagiuoli, StefanoD'Alessio, AndreaLorini, LucaFalanga, Anna +
A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation 01 - Articolo su rivista 2021 Gilardi, MaraFalanga, AnnaVanoni, Marco +
Tissue Plasminogen Activator Levels and Risk of Breast Cancer in a Case-Cohort Study on Italian Women: Results from the Moli-sani Study 01 - Articolo su rivista 2021 Marchetti M.Falanga A. +
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure 01 - Articolo su rivista 2021 Falanga A. +
Association of plasma Protein C and CCL18 levels with neurodegenerative measures in Multiple Sclerosis patients 02 - Intervento a convegno 2020 Ziliotto, NFALANGA, ANNA +
Type and dose of heparin in Covid-19: Reply 01 - Articolo su rivista 2020 Falanga A +
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment 01 - Articolo su rivista 2020 Falanga A +
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE 01 - Articolo su rivista 2020 Mantovani LGFalanga a +
Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey 01 - Articolo su rivista 2020 Falanga A +
DOACs and “newer” hemophilia therapies in COVID-19: Reply 01 - Articolo su rivista 2020 Falanga A +
ISTH interim guidance on recognition and management of coagulopathy in COVID-19 01 - Articolo su rivista 2020 Falanga A +
Clozapine-induced anemia: A case-report 01 - Articolo su rivista 2020 Falanga A +
Thrombin generation predicts early recurrence in breast cancer patients 01 - Articolo su rivista 2020 Falanga A +
Laboratory haemostasis monitoring in COVID-19 01 - Articolo su rivista 2020 Falanga A +
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer 01 - Articolo su rivista 2020 Falanga A +
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review 01 - Articolo su rivista 2020 Falanga A +
Hemostatic biomarkers in occult cancer and cancer risk prediction 01 - Articolo su rivista 2020 Marchetti M.Falanga A.
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 01 - Articolo su rivista 2020 Falanga, A +
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine 01 - Articolo su rivista 2020 Falanga A. +
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research 01 - Articolo su rivista 2020 Falanga A +